Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
Lay Description
Create a living biobank of PDOs from Stage I-III lung cancer patients.
Category
- Cancers and Other Neoplasms
- Lungs, Breathing and Bronchial
- Lung
- IRB Number
- 20180485HU
- NCT Number
- NCT03655015
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure.
- Diagnosis of lung cancer or lung mass or lymphadenopathy that will undergo tumor resection as part of standard of care
- Any clinical stage
- Adult patients ≥18 years of age
- Able and willing to complete a questionnaire on their environmental/occupational exposures and smoking/alcohol history
Exclusion Criteria
- At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.
Study Design
Arm Groups
Study Contact
Frances Crawford
(210) 450-5037
crawfordf1@uthscsa.edu
Sonia Creighton
(210) 450-1366
creighton@uthscsa.edu
Myrna Montenegro
(210) 450-5954
montenegro@uthscsa.edu
Courtney Nichols
(210) 450-1794
nicholsc2@uthscsa.edu
Mailbox Ctrc Regulatory Affairs
regaffapp@uthscsa.edu
Kathleen Rodriguez
(210) 450-1365
rodriguezk3@uthscsa.edu
Benjamin Schleif
(210) 450-1366
schleifb@uthscsa.edu
Morgan Seekatz
(210) 450-1133
seekatz@uthscsa.edu
Josephine Taverna
tavernaj@uthscsa.edu
Principal Investigator
Josephine Taverna
Principal Investigator
William Kelly